3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Triple Negative Breast Neoplasms
1
Prostatic Neoplasms
1
Opioid-Related Disorders
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Barrett Esophagus
1
Interventions
Esomeprazole
3
Radiofrequency Ablation
2
Endoscopy, Digestive System
2
rofecoxib
1
YF 476
1
X-Rays
1
Narrow Band Imaging
1
Lansoprazole
1
Endoscopy
1
Diagnostic Imaging
1
Dexlansoprazole
1
Cryosurgery
1
Blood Specimen Collection
1
Biopsy
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Barrett Esophagus
×
X-Rays
×
Clear all
NCT01209013
2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3
Withdrawn